Safety Study of MG1102 in Patients With Solid Tumors
Clinical trial NCT01809912 · TERMINATED
Trial details
- NCT number
- NCT01809912
- Sponsor
- Green Cross Corporation
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2013-03-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.